Archer Investment Corporation’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26K Hold
166
0.01% 629
2026
Q1
$25.4K Buy
166
+80
+93% +$12.3K 0.01% 629
2025
Q4
$11.9K Sell
86
-87
-50% -$11.4K ﹤0.01% 699
2025
Q3
$22.2K Hold
173
0.01% 603
2025
Q2
$20.9K Buy
173
+2
+1% +$225 0.01% 593
2025
Q1
$19.1K Hold
171
﹤0.01% 592
2024
Q4
$16.6K Hold
171
﹤0.01% 608
2024
Q3
$19.7K Buy
171
+85
+99% +$9.64K 0.01% 574
2024
Q2
$9.16K Sell
86
-3
-3% -$301 ﹤0.01% 677
2024
Q1
$8.61K Hold
89
﹤0.01% 678
2023
Q4
$8.99K Hold
89
﹤0.01% 673
2023
Q3
$9.07K Hold
89
﹤0.01% 646
2023
Q2
$8.98K Buy
89
+65
+271% +$6.5K ﹤0.01% 635
2023
Q1
$2.21K Hold
24
﹤0.01% 736
2022
Q4
$2.18K Hold
24
﹤0.01% 702
2022
Q3
$1.82K Hold
24
﹤0.01% 685
2022
Q2
$2.03K Hold
24
﹤0.01% 690
2022
Q1
$2.25K Hold
24
﹤0.01% 689
2021
Q4
$2.1K Hold
24
﹤0.01% 684
2021
Q3
$1.96K Buy
+24
New +$2.16K ﹤0.01% 649
2021
Q2
Sell
-24
Closed -$2.05K 675
2021
Q1
$2.05K Hold
24
﹤0.01% 680
2020
Q4
$2.27K Hold
24
﹤0.01% 631
2020
Q3
$2.09K Hold
24
﹤0.01% 573
2020
Q2
$2.1K Hold
24
﹤0.01% 566
2020
Q1
$2K Hold
24
﹤0.01% 542
2019
Q4
$2K Hold
24
﹤0.01% 562
2019
Q3
$2K Buy
+24
New +$2.15K ﹤0.01% 446

Other funds holding NVS

Archer Investment Corporation's NVS Position: Q2 2026 in Review

Archer Investment Corporation held its Novartis (NVS) position steady in Q2 2026 at 166 shares worth $26K. The position accounts for 0.01% of the portfolio, ranked #629.

Archer Investment Corporation first reported a position in NVS in Q3 2019 and has held it in 27 quarters since. 1,269 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Archer Investment Corporation held 166 shares of Novartis worth $26K as of Q2 2026.
  • Archer Investment Corporation left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.01% of Archer Investment Corporation's portfolio in Q2 2026, its #629 holding.
  • Archer Investment Corporation first reported a position in Novartis in Q3 2019 and has held it in 27 quarters since.
  • 1,269 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Archer Investment Corporation's 13F filing for Q2 2026, filed 3 Aug 2026.